2003
DOI: 10.1073/pnas.0730775100
|View full text |Cite
|
Sign up to set email alerts
|

Epigenetic abnormalities associated with a chromosome 18(q21-q22) inversion and a Gilles de la Tourette syndrome phenotype

Abstract: Gilles de la Tourette syndrome (GTS) is a potentially debilitating neuropsychiatric disorder defined by the presence of both vocal and motor tics. Despite evidence that this and a related phenotypic spectrum, including chronic tics (CT) and Obsessive Compulsive Disorder (OCD), are genetically mediated, no gene involved in disease etiology has been identified. Chromosomal abnormalities have long been proposed to play a causative role in isolated cases of GTS spectrum phenomena, but confirmation of this hypothes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
48
0

Year Published

2004
2004
2015
2015

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 73 publications
(49 citation statements)
references
References 25 publications
1
48
0
Order By: Relevance
“…These yielded several candidate regions, however none of the involved breakpoints has yet led to a final breakthrough. Candidate regions or genes that have been indicated by chromosomal aberrations include chromosomes 9p, 16 7q22, 18q22, 17 8q22, 18 a de novo duplication indicating the IMMP2L gene at 7q31, 19 disruption of the CNTNAP2 gene at chromosome 7q35-36 in three affected individuals in one family, 20 a chromosome 18q21-22 inversion, 21 and a translocation breakpoint at 8q. 22 Finally, a very recent study in a child with GTS has identified a de novo chromosome 13q inversion, indicating the Slit and Trk-like family member 1 (SLITRK1) geneinvolved in dendritic growth -to be a candidate gene.…”
Section: Introductionmentioning
confidence: 99%
“…These yielded several candidate regions, however none of the involved breakpoints has yet led to a final breakthrough. Candidate regions or genes that have been indicated by chromosomal aberrations include chromosomes 9p, 16 7q22, 18q22, 17 8q22, 18 a de novo duplication indicating the IMMP2L gene at 7q31, 19 disruption of the CNTNAP2 gene at chromosome 7q35-36 in three affected individuals in one family, 20 a chromosome 18q21-22 inversion, 21 and a translocation breakpoint at 8q. 22 Finally, a very recent study in a child with GTS has identified a de novo chromosome 13q inversion, indicating the Slit and Trk-like family member 1 (SLITRK1) geneinvolved in dendritic growth -to be a candidate gene.…”
Section: Introductionmentioning
confidence: 99%
“…1B). Using additional mapping data from the two previously reported 18q22 rearrangements, our patient's breakpoint was found to map to a genomic position approximately 4.7 Mb centromeric to the 18q22 inversion breakpoint reported by State et al [2003] and approximately 5.5 Mb centromeric to the previously reported 18q22 translocation breakpoint described by Boghosian-Sell et al [1996].…”
Section: Resultsmentioning
confidence: 83%
“…Boghosian-Sell et al [1996] presented mapping data on a pedigree in which GTS, CTD, and OCD segregated with a t(7;18)(q22-31;q22) translocation. More recently, the fine mapping of a patient carrying an inv(18)(q21-q22) inversion with CTD and OCD was reported [State et al, 2003].…”
Section: Introductionmentioning
confidence: 98%
See 1 more Smart Citation
“…Epigenetic reprogramming in diseased cells is often observed to occur with changes in replication timing patterns, with changes in replication being observed with chromosomal rearrangements in cancer cell lines (D'Antoni et al, 2004;Gondor and Ohlsson, 2009;State et al, 2003). Better detection of prostate cancer may come in the form of measuring replication timing changes observed in peripheral blood lymphocytes undergoing aneuploidy (Dotan et al, 2004).…”
Section: Measuring Replication To Combat Cancermentioning
confidence: 99%